Safety, tolerability, PK [pharmacokinetics] and PD [pharmacodynamics] of LY2405319 after multiple subcutaneous injections in subjects with type 2 diabetes

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 28 Sep 2010

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

10 Sep 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
23 Sep 2008 Status changed from not yet recruiting to recruiting.
12 Aug 2008 The planned initiation date for this trial is now August 2008 accoring to clincialtrials.gov record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com